Skip to main content
OpenTrials
Completed

NCT Number: NCT02149940

Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients.

Heart failure therapies (e.g. beta blockers) have been successful in decreasing mortality rates, as well as diminishing hospitalizations. Also, pharmacist collaboration has been shown to have a beneficial impact on heart failure related outcomes. Regardless, a high residual event rate is to be noted.

In our pilot study, we wished to document whether a clinical pharmacist could still play a role in the heart failure management of an elderly inpatient heart failure population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Heart Failure Cardiovascular Diseases Frailty Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

75 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University Hospitals Leuven

Leuven, Flemish Brabant, 3000, Belgium

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 75 years or older
  • diagnosis of previous or new heart failure based on signs and symptoms as defined by the 'European Society of Cardiology guidelines on acute and chronic heart failure'
  • diagnosis had to be confirmed by a recent echocardiogram

Exclusion criteria

  • not Dutch speaking
  • treatment restrictions had been applied on admission

Treatment and study plan

heart-failure related pharmaceutical intervention

Other

Primary outcomes

  1. the number of heart-failure related pharmaceutical interventions

    Time frame: during hospital stay (average of 14 days)

Secondary outcomes

  1. acceptance rate of the pharmaceutical interventions

    Time frame: during hospital stay (average of 14 days)

  2. clinical feasibility of the accepted interventions

    Time frame: during hospital stay (average of 14 days)

Sponsors and collaborators

Lead sponsor

Universitaire Ziekenhuizen KU Leuven

Other

Registry information

Official study title

Feasibility of Pharmaceutical Interventions in Elderly Heart Failure Patients: a Pilot Study.

Acronym: RASP-HF

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
May 29, 2014
Registry last updated
May 29, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.